| SARS-CoV-2 transmission from people without COVID-19 symptoms MA Johansson, TM Quandelacy, S Kada, PV Prasad, M Steele, JT Brooks, ... JAMA network open 4 (1), e2035057-e2035057, 2021 | 1087 | 2021 |
| Genomic surveillance for SARS-CoV-2 variants: predominance of the Delta (B. 1.617. 2) and Omicron (B. 1.1. 529) variants—United States, June 2021–January 2022 AS Lambrou MMWR. Morbidity and mortality weekly report 71, 2022 | 147 | 2022 |
| Estimated number of COVID-19 infections, hospitalizations, and deaths prevented among vaccinated persons in the US, December 2020 to September 2021 MK Steele, A Couture, C Reed, D Iuliano, M Whitaker, H Fast, AJ Hall, ... JAMA Network Open 5 (7), e2220385-e2220385, 2022 | 87 | 2022 |
| Genomic surveillance for SARS-CoV-2 variants circulating in the United States, December 2020–May 2021 P Paul MMWR. Morbidity and mortality weekly report 70, 2021 | 83 | 2021 |
| Estimating under-recognized COVID-19 deaths, United States, march 2020-may 2021 using an excess mortality modelling approach AD Iuliano, HH Chang, NN Patel, R Threlkel, K Kniss, J Reich, M Steele, ... The Lancet Regional Health–Americas 1, 2021 | 79 | 2021 |
| Norovirus transmission dynamics: a modelling review KAM Gaythorpe, CL Trotter, B Lopman, M Steele, AJK Conlan Epidemiology & Infection 146 (2), 147-158, 2018 | 58 | 2018 |
| Targeting pediatric versus elderly populations for norovirus vaccines: a model-based analysis of mass vaccination options MK Steele, JV Remais, M Gambhir, JW Glasser, A Handel, UD Parashar, ... Epidemics 17, 42-49, 2016 | 31 | 2016 |
| Modeling effectiveness of testing strategies to prevent coronavirus disease 2019 (COVID-19) in nursing homes—United States, 2020 I See, P Paul, RB Slayton, MK Steele, MJ Stuckey, L Duca, A Srinivasan, ... Clinical Infectious Diseases 73 (3), e792-e798, 2021 | 30 | 2021 |
| Strain surveillance and emerging variants bioinformatic working group; strain surveillance and emerging variants NS3 working group. Genomic surveillance for SARS-CoV-2 variants … AS Lambrou, P Shirk, MK Steele, P Paul, CR Paden, B Cadwell, ... MMWR Morb Mortal Wkly Rep 71 (6), 206-211, 2022 | 24 | 2022 |
| Characterizing norovirus transmission from outbreak data, United States MK Steele, ME Wikswo, AJ Hall, K Koelle, A Handel, K Levy, LA Waller, ... Emerging Infectious Diseases 26 (8), 1818, 2020 | 19 | 2020 |
| Estimating COVID-19 hospitalizations in the united states with surveillance data using a bayesian hierarchical model: modeling study A Couture, AD Iuliano, HH Chang, NN Patel, M Gilmer, M Steele, ... JMIR Public Health and Surveillance 8 (6), e34296, 2022 | 16 | 2022 |
| Point prevalence estimates of activity-limiting long-term symptoms among United States adults≥ 1 month after reported severe acute respiratory syndrome coronavirus 2 infection … MW Tenforde, OJ Devine, HE Reese, BJ Silk, AD Iuliano, R Threlkel, ... The Journal of Infectious Diseases 227 (7), 855-863, 2023 | 14 | 2023 |
| Modeling strategies for the allocation of SARS-CoV-2 vaccines in the United States J Walker, P Paul, K Dooling, S Oliver, P Prasad, M Steele, PA Gastañaduy, ... Vaccine 40 (14), 2134-2139, 2022 | 12 | 2022 |
| Disease burden and seasonal impact of improving rotavirus vaccine coverage in the United States: A modeling study CE Ai, M Steele, B Lopman PloS one 15 (2), e0228942, 2020 | 12 | 2020 |
| Targeting pediatric versus elderly populations for norovirus vaccines: a model-based analysis of mass vaccination options. Epidemics. 2016; 17: 42–9 MK Steele, JV Remais, M Gambhir, JW Glasser, A Handel, UD Parashar FIGURE LEGEND, 0 | 7 | |
| Population-level human secretor status is associated with genogroup 2 type 4 norovirus predominance CJ Arrouzet, K Ellis, A Kambhampati, Y Chen, M Steele, B Lopman The Journal of Infectious Diseases 221 (11), 1855-1863, 2020 | 6 | 2020 |
| The population-level impacts of excluding norovirus-infected food workers from the workplace: a mathematical modeling study W Yang, M Steele, B Lopman, JS Leon, AJ Hall American Journal of Epidemiology 188 (1), 177-187, 2019 | 6 | 2019 |
| Cost-effectiveness of pediatric norovirus vaccination in daycare settings LN Steimle, J Havumaki, MC Eisenberg, JNS Eisenberg, LA Prosser, ... Vaccine 39 (15), 2133-2145, 2021 | 5 | 2021 |
| Multimodeling approach to evaluating the efficacy of layering pharmaceutical and nonpharmaceutical interventions for influenza pandemics PV Prasad, MK Steele, C Reed, LA Meyers, Z Du, R Pasco, ... Proceedings of the National Academy of Sciences 120 (28), e2300590120, 2023 | 4 | 2023 |
| Predicting the long-term impact of rotavirus vaccination in 112 countries from 2006 to 2034: A transmission modeling analysis ANM Kraay, MK Steele, JM Baker, EW Hall, A Deshpande, BF Saidzosa, ... Vaccine 40 (46), 6631-6639, 2022 | 4 | 2022 |
Rachel B. SlaytonEpidemiologist, Centers for Disease Control and PreventionVerified email at cdc.gov
